Bedaquiline Fumarate + Cyp3a Inhibitors Moderate And Strong Interaction
Contraindicatedinteraction on record
Description
Coadministration may decrease systemic exposure of bedaquiline. Avoid use of strong and moderate CYP3A4 inducers with SIRTURO.
Mechanism
CYP3A4 enzyme induction decreases bedaquiline systemic exposure
Source: NLP:bedaquiline fumarate